Time to buy GILD. Dropped too far. Remesvidir

Time to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.

Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
Beyond Technical AnalysisChart PatternsTrend Analysis

Disclaimer